1. Home
  2. IMNM vs YEXT Comparison

IMNM vs YEXT Comparison

Compare IMNM & YEXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • YEXT
  • Stock Information
  • Founded
  • IMNM 2006
  • YEXT 2006
  • Country
  • IMNM United States
  • YEXT United States
  • Employees
  • IMNM N/A
  • YEXT N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • YEXT EDP Services
  • Sector
  • IMNM Health Care
  • YEXT Technology
  • Exchange
  • IMNM Nasdaq
  • YEXT Nasdaq
  • Market Cap
  • IMNM 945.8M
  • YEXT 1.0B
  • IPO Year
  • IMNM 2020
  • YEXT 2017
  • Fundamental
  • Price
  • IMNM $10.60
  • YEXT $8.18
  • Analyst Decision
  • IMNM Strong Buy
  • YEXT Strong Buy
  • Analyst Count
  • IMNM 5
  • YEXT 4
  • Target Price
  • IMNM $26.40
  • YEXT $9.44
  • AVG Volume (30 Days)
  • IMNM 965.4K
  • YEXT 625.3K
  • Earning Date
  • IMNM 08-11-2025
  • YEXT 09-03-2025
  • Dividend Yield
  • IMNM N/A
  • YEXT N/A
  • EPS Growth
  • IMNM N/A
  • YEXT N/A
  • EPS
  • IMNM N/A
  • YEXT N/A
  • Revenue
  • IMNM $10,938,000.00
  • YEXT $434,450,000.00
  • Revenue This Year
  • IMNM N/A
  • YEXT $8.92
  • Revenue Next Year
  • IMNM $259.34
  • YEXT $5.14
  • P/E Ratio
  • IMNM N/A
  • YEXT N/A
  • Revenue Growth
  • IMNM N/A
  • YEXT 8.38
  • 52 Week Low
  • IMNM $5.15
  • YEXT $4.69
  • 52 Week High
  • IMNM $16.81
  • YEXT $9.15
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 60.20
  • YEXT 50.21
  • Support Level
  • IMNM $10.33
  • YEXT $8.38
  • Resistance Level
  • IMNM $11.08
  • YEXT $8.63
  • Average True Range (ATR)
  • IMNM 0.60
  • YEXT 0.18
  • MACD
  • IMNM 0.04
  • YEXT -0.02
  • Stochastic Oscillator
  • IMNM 72.31
  • YEXT 53.63

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About YEXT Yext Inc.

Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.

Share on Social Networks: